![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: KIAA2026 |
Gene summary for KIAA2026 |
![]() |
Gene information | Species | Human | Gene symbol | KIAA2026 | Gene ID | 158358 |
Gene name | KIAA2026 | |
Gene Alias | KIAA2026 | |
Cytomap | 9p24.1 | |
Gene Type | protein-coding | GO ID | NA | UniProtAcc | Q5HYC2 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
158358 | KIAA2026 | HTA11_3410_2000001011 | Human | Colorectum | AD | 1.98e-25 | -6.81e-01 | 0.0155 |
158358 | KIAA2026 | HTA11_2487_2000001011 | Human | Colorectum | SER | 3.18e-02 | -3.61e-01 | -0.1808 |
158358 | KIAA2026 | HTA11_2951_2000001011 | Human | Colorectum | AD | 7.33e-03 | -6.86e-01 | 0.0216 |
158358 | KIAA2026 | HTA11_3361_2000001011 | Human | Colorectum | AD | 7.62e-11 | -6.84e-01 | -0.1207 |
158358 | KIAA2026 | HTA11_83_2000001011 | Human | Colorectum | SER | 3.24e-02 | -3.24e-01 | -0.1526 |
158358 | KIAA2026 | HTA11_696_2000001011 | Human | Colorectum | AD | 1.69e-12 | -4.54e-01 | -0.1464 |
158358 | KIAA2026 | HTA11_866_2000001011 | Human | Colorectum | AD | 3.85e-09 | -4.59e-01 | -0.1001 |
158358 | KIAA2026 | HTA11_1391_2000001011 | Human | Colorectum | AD | 9.08e-06 | -3.85e-01 | -0.059 |
158358 | KIAA2026 | HTA11_5216_2000001011 | Human | Colorectum | SER | 7.95e-03 | -5.19e-01 | -0.1462 |
158358 | KIAA2026 | HTA11_546_2000001011 | Human | Colorectum | AD | 1.14e-04 | -4.80e-01 | -0.0842 |
158358 | KIAA2026 | HTA11_7862_2000001011 | Human | Colorectum | AD | 2.32e-02 | -5.70e-01 | -0.0179 |
158358 | KIAA2026 | HTA11_866_3004761011 | Human | Colorectum | AD | 1.47e-18 | -6.69e-01 | 0.096 |
158358 | KIAA2026 | HTA11_8622_2000001021 | Human | Colorectum | SER | 3.44e-03 | -5.82e-01 | 0.0528 |
158358 | KIAA2026 | HTA11_6801_2000001011 | Human | Colorectum | SER | 2.88e-02 | -6.39e-01 | 0.0171 |
158358 | KIAA2026 | HTA11_10711_2000001011 | Human | Colorectum | AD | 2.25e-08 | -5.97e-01 | 0.0338 |
158358 | KIAA2026 | HTA11_7696_3000711011 | Human | Colorectum | AD | 1.45e-13 | -5.10e-01 | 0.0674 |
158358 | KIAA2026 | HTA11_6818_2000001021 | Human | Colorectum | AD | 3.35e-07 | -5.00e-01 | 0.0588 |
158358 | KIAA2026 | HTA11_99999970781_79442 | Human | Colorectum | MSS | 9.96e-15 | -4.54e-01 | 0.294 |
158358 | KIAA2026 | HTA11_99999971662_82457 | Human | Colorectum | MSS | 3.69e-09 | -4.35e-01 | 0.3859 |
158358 | KIAA2026 | HTA11_99999973899_84307 | Human | Colorectum | MSS | 2.67e-08 | -6.67e-01 | 0.2585 |
Page: 1 2 3 4 5 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
Page: 1 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
KIAA2026 | SNV | Missense_Mutation | c.4612N>A | p.Ala1538Thr | p.A1538T | Q5HYC2 | protein_coding | tolerated(1) | benign(0) | TCGA-AP-A051-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD | |
KIAA2026 | SNV | Missense_Mutation | novel | c.5465A>G | p.Asn1822Ser | p.N1822S | Q5HYC2 | protein_coding | tolerated(0.81) | benign(0.005) | TCGA-AP-A056-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
KIAA2026 | SNV | Missense_Mutation | c.1720C>T | p.Arg574Cys | p.R574C | Q5HYC2 | protein_coding | tolerated(0.07) | benign(0) | TCGA-AP-A056-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD | |
KIAA2026 | SNV | Missense_Mutation | rs778316251 | c.1258G>A | p.Glu420Lys | p.E420K | Q5HYC2 | protein_coding | deleterious(0.02) | possibly_damaging(0.743) | TCGA-AP-A056-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
KIAA2026 | SNV | Missense_Mutation | rs771486409 | c.6053N>T | p.Ser2018Phe | p.S2018F | Q5HYC2 | protein_coding | deleterious(0) | possibly_damaging(0.838) | TCGA-AP-A0LM-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | III/IV | Chemotherapy | cisplatin | SD |
KIAA2026 | SNV | Missense_Mutation | c.4274N>C | p.Phe1425Ser | p.F1425S | Q5HYC2 | protein_coding | tolerated(0.14) | benign(0.037) | TCGA-AP-A0LM-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | III/IV | Chemotherapy | cisplatin | SD | |
KIAA2026 | SNV | Missense_Mutation | c.1720N>T | p.Arg574Cys | p.R574C | Q5HYC2 | protein_coding | tolerated(0.07) | benign(0) | TCGA-AP-A0LM-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | III/IV | Chemotherapy | cisplatin | SD | |
KIAA2026 | SNV | Missense_Mutation | novel | c.4141N>A | p.Asp1381Asn | p.D1381N | Q5HYC2 | protein_coding | tolerated(0.69) | benign(0) | TCGA-AP-A1DK-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
KIAA2026 | SNV | Missense_Mutation | novel | c.689N>A | p.Arg230Gln | p.R230Q | Q5HYC2 | protein_coding | deleterious(0) | probably_damaging(0.989) | TCGA-AP-A1DK-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
KIAA2026 | SNV | Missense_Mutation | c.1040C>A | p.Ser347Tyr | p.S347Y | Q5HYC2 | protein_coding | deleterious(0.02) | possibly_damaging(0.611) | TCGA-AX-A05Z-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | III/IV | Chemotherapy | adriamycin | SD |
Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |